FULVEKAST

Send Enquiry



Description

Description

Composition:
Each ml contains:
Fulvestrant IP 50 mg
Ethanol (96%) USP 10 % w/v
PACKING: 1 Vial Injection

INDICATIONS: Fulvestrant is indicated for
the treatment of hormone receptor positive
Metastatic Breast Cancer in
postmenopausal women with disease
progression following antiestrogen therapy

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “FULVEKAST”

Your email address will not be published. Required fields are marked *

Download Product PDF Attachment